ABSTRACT
Purpose: Statins are widely used in combination with omega-3 fatty acids for the treatment of patients with dyslipidemia. The aim of this study was to compare the pharmacokinetic (PK) profiles of atorvastatin and omega-3-acid ethyl esters between fixed-dose combination (FDC) and loose combination in healthy subjects. Methods: A randomized, open-label, single-dose, 2-sequence, 2-treatment, 4-period replicated crossover study was performed. Subjects were randomly assigned to one of the 2 sequences and alternately received four FDC soft capsules of atorvastatin/omega-3-acid ethyl esters (10/1000 mg) or a loose combination of atorvastatin tablets (10 mg × 4) and omega-3-acid ethyl ester soft capsules (1000 mg× 4) for four periods, each period accompanied by a high-fat meal. Serial blood samples were collected for PK analysis of atorvastatin, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). PK parameters were calculated by a non-compartmental analysis. The geometric mean ratio (GMR) and its 90% confidence interval (CI) of the FDC to the loose combination were calculated to compare PK parameters. Results: A total of 43 subjects completed the study as planned. The GMR (90% CI) of FDC to loose combination for maximum concentration (Cmax) and area under the time-concentration curve from zero to the last measurable point (AUClast) were 1.0931 (1.0054-1.1883) and 0.9885 (0.9588-1.0192) for atorvastatin, 0.9607 (0.9068-1.0178) and 0.9770 (0.9239-1.0331) for EPA, and 0.9961 (0.9127-1.0871) and 0.9634 (0.8830-1.0512) for DHA, respectively. The intra-subject variability for Cmax and AUClast of DHA was 30.8% and 37.5%, respectively, showing high variability. Both the FDC and the loose combination were safe and well tolerated. Conclusion: The FDC of atorvastatin and omega-3-acid ethyl esters showed comparable PK characteristics to the corresponding loose combination, offering a convenient therapeutic option for the treatment of dyslipidemia.
Subject(s)
Dyslipidemias , Eicosapentaenoic Acid , Humans , Male , Atorvastatin , Eicosapentaenoic Acid/pharmacokinetics , Healthy Volunteers , Cross-Over Studies , Docosahexaenoic Acids , Republic of Korea , Drug Combinations , Area Under CurveABSTRACT
In this paper, the volume integral equation method (VIEM) is introduced for the numerical analysis of an infinite isotropic solid containing a variety of single isotropic/anisotropic spheroidal inclusions. In order to introduce the VIEM as a versatile numerical method for the three-dimensional elastostatic inclusion problem, VIEM results are first presented for a range of single isotropic/orthotropic spherical, prolate and oblate spheroidal inclusions in an infinite isotropic matrix under uniform remote tensile loading. We next considered single isotropic/orthotropic spherical, prolate and oblate spheroidal inclusions in an infinite isotropic matrix under remote shear loading. The authors hope that the results using the VIEM cited in this paper will be established as reference values for verifying the results of similar research using other analytical and numerical methods.
ABSTRACT
Metformin has several problems such as low bioavailability, short half-life, and narrow absorption window, sustained and site-specific drug delivery system is required. Floating drug delivery systems are very useful to achieve these purposes. However, conventional floating systems have several limitations; lag time, a high proportion of excipient in the tablet, using non-biocompatible excipient, and requirement of a complicated procedure. To overcome these obstacles, we developed a hollow-core floating tablet (HCFT). The HCFT immediately floated in pH 1.2, 4.0, 6.8 medium, and even distilled water. The floating duration time of HCFT was>24 h. From the in vitro release study, it was confirmed that HCFT showed the sustain release profile of metformin for 12 h. Water uptake and matrix erosion were evaluated for predicting the buoyancy and drug release kinetics of HCFT in the body. Factor analysis was applied to optimize the formulation. There were significant (p < 0.05) differences in metformin plasma concentration of 4 h and 6 h between two groups. Compared with Glucophage® XR, the relative bioavailability of metformin HCFT was 123.81 ± 3.52%. The X-ray imaging of optimized formulation revealed that HCFT was constantly floating in the stomach region of the rabbit, thereby indicating improved gastric retention for>6 h. Consequently, all the findings indicate that HCFT could be an effective gastric retention system and applied extensively to other drugs with narrow absorption windows.
Subject(s)
Metformin , Animals , Biological Availability , Cellulose , Chemistry, Pharmaceutical , Delayed-Action Preparations , Drug Delivery Systems , Rabbits , TabletsABSTRACT
Obesity is a major health concern worldwide, and it is leading to worsening disease morbidity and mortality. Herbal supplements and diet-based therapies have attracted interest in the treatment of obesity. It is known that Garcinia cambogia (GA) and mulberry leaf, which contain polyphenols, have anti-obesity activity. Herein, we developed a combined tablet consisting of GA extract and bioconverted mulberry leaf extract (BMUL) using a statistical design approach. The ratio and amount of sustained polymers were set as factors. In the cell study, the combination of GA and BMUL showed synergistic anti-obesity activity. In a statistical model, the optimized amounts of hydroxypropyl methylcellulose 2208 (HPMC 2208) and polyethylene oxide 303 (POLYOX 303) were 41.02% and 58.98%, respectively. Additionally, the selected ratio of microcrystalline cellulose (MCC) was 0.33. When the release, hardness, and friability of the GABMUL tablet were evaluated, the error percentages of the response were lower than 10%. This indicates that the GABMUL tablet was successfully prepared.
ABSTRACT
A simple, sensitive, and rapid UHPLC-MS/MS method was developed for the simultaneous determination of veratraldehyde and its metabolite veratric acid in rat plasma. Cinnamaldehyde was used as an internal standard (IS) and the one-step protein precipitation method with 0.2% formic acid in acetonitrile (mobile phase B) was used for the sample extraction. Reversed C18 column (YMC-Triart C18 column, 50 mm × 2.0 mm, 1.9 µm) was used for chromatographic separation and was maintained at 30 °C. The total run time was 4.5 min and the electrospray ionization in positive mode was used with the transition m/z 167.07 â 139.00 for veratraldehyde, m/z 183.07 â 139.00 for veratric acid, and m/z 133.00 â 55.00 for IS. The developed method exhibited good linearity (r2 ≥ 0.9977), and the lower limits of quantification ranged from 3 to 10 ng/mL for the two analytes. Intra-day precision and accuracy parameters met the criteria (within ±15%) during the validation. The bioanalytical method was applied for the determination of veratraldehyde and veratric acid in rat plasma after oral and percutaneous administration of 300 and 600 mg/kg veratraldehyde. Using the analytical methods established in this study, we can confirm the absorption and metabolism of veratraldehyde in rats for various routes.
Subject(s)
Benzaldehydes , Plasma/metabolism , Vanillic Acid/analogs & derivatives , Administration, Cutaneous , Administration, Oral , Animals , Benzaldehydes/pharmacokinetics , Benzaldehydes/pharmacology , Male , Rats , Tandem Mass Spectrometry , Vanillic Acid/pharmacokinetics , Vanillic Acid/pharmacologyABSTRACT
A surge of interest in microneedle (MN) vaccines as a novel vaccination system has emerged. Before the clinical application of MN vaccine, an assessment of potential biological risks to skin and quality control of MN must be performed. Therefore, the present study aims to evaluate the physicochemical properties of MN and to evaluate the histological changes and inflammatory cell infiltrations after the application of MN with hepatitis B surface antigen (HBsAg). During in vitro and in vivo release testing, HBsAg MN released over 70% of HBsAg at 30 min. During the pyrogen test of HBsAg MN in rabbit, no rabbit showed an individual rise in temperature of 0.5 °C or more. MN with HBsAg produced the moderate immunization in mice. MN application did not alter the thickness of dermal and epidermal layers in mice. In addition, the topical applications of MN and MN for hepatitis B vaccine did not acutely induce the inflammation, allergic reaction, dermal toxicity and skin irritation. Thus, the MN system for the delivery of HBsAg could be the promising technology in the hepatitis B vaccination.
ABSTRACT
Docetaxel (DTX) has clinical efficacy in the treatment of breast cancer, but it is difficult to develop a product for oral administration, due to low solubility and permeability. This study focused on preparing a self-microemulsifying drug delivery system (SME) loaded with DTX-phospholipid complex (DTX@PLC), to improve the dissolution and gastrointestinal (GI) permeability of DTX. A dual technique combining the phospholipid complexation and SME formulation described as improving upon the disadvantages of DTX has been proposed. We hypothesized that the complexation of DTX with phospholipids can improve the lipophilicity of DTX, thereby increasing the affinity of the drug to the cell lipid membrane, and simultaneously improving permeability through the GI barrier. Meanwhile, DTX@PLC-loaded SME (DTX@PLC-SME) increases the dissolution and surface area of DTX by forming a microemulsion in the intestinal fluid, providing sufficient opportunity for the drug to contact the GI membrane. First, we prepared DTX@PLC-SME by combining dual technologies, which are advantages for oral absorption. Next, we optimized DTX@PLC-SME with nanosized droplets (117.1 nm), low precipitation (8.9%), and high solubility (33.0 mg/g), which formed a homogeneous microemulsion in the aqueous phase. Dissolution and cellular uptake studies demonstrated that DTX@PLC-SME showed 5.6-fold higher dissolution and 2.3-fold higher DTX uptake in Caco-2 cells than raw material. In addition, an ex vivo gut sac study confirmed that DTX@PLC-SME improved GI permeability of DTX by 2.6-fold compared to raw material. These results suggested that DTX@PLC-SME can significantly overcome the disadvantages of anticancer agents, such as low solubility and permeability.
ABSTRACT
In this study, we developed ticagrelor-dispersed nanosuspension (TCG-NSP) to enhance the dissolution and oral bioavailability of ticagrelor (TCG) through a statistical design approach. TCG, a reversible P2Y12 receptor antagonist, is classified as a biopharmaceutics classification system (BCS) class IV drug with low solubility and permeability, resulting in low oral bioavailability. Nanosuspension (NSP) is an efficient pharmaceutical technique for overcoming the disadvantages. First, we optimized TCG-NSP consisting of D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) and polyvinyl alcohol (PVA), which exhibited homogeneously dispersed TCG particle (233 nm) and low precipitation (3%). Characterization studies demonstrated that TCG-NSP provided amorphous TCG particles and supersaturation effect, resulting in higher dissolution than a commercial product. In addition, everted gut sac and pharmacokinetic studies confirmed that TCG-NSP improved the gastrointestinal permeation of TCG by 2.8-fold compared to commercial product, thereby enhancing the oral bioavailability (2.2-fold). These results suggested that TCG-NSP could be successfully used as an efficient pharmaceutical formulation to achieve the enhanced dissolution and oral bioavailability of TCG.
Subject(s)
Drug Delivery Systems/methods , Nanoparticles/metabolism , Polyvinyl Alcohol/metabolism , Ticagrelor/metabolism , Vitamin E/metabolism , Administration, Oral , Animals , Biological Availability , Caco-2 Cells , Cell Survival/drug effects , Cell Survival/physiology , Dose-Response Relationship, Drug , Drug Liberation/drug effects , Drug Liberation/physiology , Humans , Male , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Organ Culture Techniques , Polyvinyl Alcohol/administration & dosage , Polyvinyl Alcohol/chemistry , Rats , Rats, Sprague-Dawley , Solubility , Ticagrelor/administration & dosage , Ticagrelor/chemistry , Vitamin E/administration & dosage , Vitamin E/chemistryABSTRACT
Ticagrelor (TCG) has been used as an antiplatelet agent for acute coronary syndrome patients. The aim of this research was to establish a population pharmacokinetic/pharmacodynamic (PK/PD) model of TCG and to apply the model for predicting the PD response of the TCG-loaded self-microemulsifying drug delivery system (TCG-SME) in rats. Pure TCG and TCG-SME (2, 5, and 10 mg/kg of TCG) were orally administered to male Sprague-Dawley rats. Plasma samples were collected at scheduled time-points and then analyzed for TCG plasma concentrations and antiplatelet effects. The inhibition of platelet aggregation of TCG was measured as a PD response. The PK profiles of pure TCG and TCG-SME could be well-explained with a two-compartment PK model. The accuracy of the PK model was assessed with a goodness-of-fit plot and conditional weight residual error (CWRES). Also, the visual predictive check was investigated based on the predictions. A population PK/PD model for pure TCG was established as an indirect response Emax model linked to the two-compartment PK model of pure TCG. The PK/PD model proposed a suitable fitting to link the plasma concentration of TCG simultaneously with platelet aggregation. Based on the PK data of TCG-SME, as well as the established PK/PD model of pure TCG, the PD profiles of TCG-SME were simulated. TCG-SME was more effective in inducing the antiplatelet effect than pure TCG at equivalent doses of TCG. The accuracy of the simulation was verified by comparing the simulated PD profile with the profile observed in rats. The observations were close to the model simulations. In addition, the values of CWRES were almost within ±2. In conclusion, the PK/PD modeling approach can provide a way for predicting mathematically the PD responses from PK profiles of other TCG formulations and a conceptual prediction for future clinical assessment.
Subject(s)
Blood Platelets/drug effects , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation Inhibitors/pharmacokinetics , Ticagrelor/pharmacology , Ticagrelor/pharmacokinetics , Animals , Drug Delivery Systems/methods , Male , Models, Biological , Platelet Aggregation/drug effects , Rats , Rats, Sprague-DawleyABSTRACT
Recently, Achyranthis radix extract has been studied as a therapeutic agent for dry eye disease that occurs from fine dust. The aim of this study was the development of Achyranthis radix extract-loaded eye drop formulations using lubricants, generally used for artificial tear eye drops. Ecdysterone was used as a marker compound for Achyranthis radix extract and 1% Achyranthis radix extract solution contained 14.37 ± 0.04 µg/mL of ecdysterone. Before formulation studies, a new method was performed to evaluate pigmentation, which might be caused by eye drops of herbal extract. A comparative study of the water retention ability of each formulation and ability to prevent the death of conjunctival epithelial cells in dry conditions was conducted. Moreover, treatment of Achyranthis radix extract (USL) eye drop formulation exhibited a significant inhibitory effect on inflammation in a concentration-dependent manner. The long-term and accelerated stability tests showed that lubricants could contribute to the stability of herbal extracts in solution. In conclusion, hyaluronic acid showed a good effect on the development of eye drop formulation using Achyranthis radix extracts for treating dry eye disease.
ABSTRACT
Treatment of skin infection by dermatophytes is still limited, and the application of conventional topical formulations (ointments, creams, etc.) cause patient discomfort due to repeated administration and low efficacy. This study describes the film-forming system (FFS) hybridized with econazole (ECO)-loaded nanostructured lipid carriers (NLC) for enhanced antifungal activity against dermatophytes. We assumed that the application of NLC could effectively increase the skin permeability of ECO, thereby suppressing the growth of dermatophytes in stratum corneum as well as in epidermis. Meanwhile, ECO-NLC hybrid FFS (ECO-NLC@FFS) could increase the adhesion of ECO-NLC to the skin and prolong the antifungal activity of ECO. First, we optimized ECO-NLC, which shows nanosized particle (199â¯nm), high encapsulation efficiency (92.5%), and biocompatibility. ECO-NLC@FFS formed a transparent, homogeneous, and hard-to-remove film after topical application. In vitro skin permeation and deposition studies demonstrated that ECO-NLC@FFS showed 1.5-fold higher skin permeation and 3-fold higher ECO deposition in the epidermis layer than a commercial product, which resulted from the nanosized particle and its occlusion effect. And, ex vivo and in vivo antifungal activity studies confirmed that ECO-NLC@FFS improved the skin adhesion of ECO-NLC, thereby allowing ECO to be continuously exposed to the infection sited and reducing the number of applications with a single dose. These results showed that this hybrid system could be a potential for effectively improving the efficacy of antifungal agents and the patient compliance in the treatment of dermatophytes. STATEMENT OF SIGNIFICANCE: Treatment of skin infection by dermatophytes is difficult due to the inconvenience and low efficacy of conventional topical formulations. Here, we demonstrated the potential of a film-forming system (FFS) hybridized with nanostructured lipid carriers (NLC). First, we confirmed that the enhanced skin permeability of drug was improved by NLC. In addition, the hybridization of NLC with FFS improved the skin adhesion of NLC, allowing the drug to exhibit a sustained release profile and prolong antifungal activity. Given the maximized antifungal activity, this hybrid system can be used as a potential pharmaceutical technique to improve patient convenience and achieve complete treatment of skin infection.
Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Biofilms/drug effects , Drug Carriers/chemistry , Econazole/pharmacology , Lipids/chemistry , Nanostructures/chemistry , Animals , Cell Death/drug effects , Cell Survival/drug effects , HaCaT Cells , Humans , Male , Mice, Inbred ICR , Microbial Sensitivity Tests , Nanostructures/ultrastructure , Permeability , Rats, Sprague-Dawley , Skin/drug effects , Tissue Distribution/drug effectsABSTRACT
The aim of this study was to solidify a ticagrelor loaded self-microemulsifying drug delivery system (TCG-SM) with enhanced dissolution and bioavailability of ticagrelor (TCG) for developing TCG-SM granules and tablets. TCG was dissolved in the self-microemulsifying drug delivery system (SMEDDS) and TCG-SM was solidified by adsorption to the optimized adsorbent through statistical design. In order to select an appropriate adsorbent, the physical properties (bulk density, tapped density, angle of repose, and liquid adsorption capacity) of silica-based adsorbents (Neusilin US2, Florite R, Aerosil 200, and Florite PS-10) and non silica-based adsorbents (Avicel PH102, Pharmatose 100M, Pearlitol 200, LH-11, and Emcompress) were investigated. Neusilin US2 and Florite R were selected as suitable adsorbents and their mixing ratios were optimized using statistical experimental design. The predicted values of physical properties by statistical design showed the error percentage of <10% compared to actual values. As a result of the statistical approach, TCG-SM (490â¯mg) was successfully solidified with Nesulin US2 (167.8â¯mg) and Florite R (82.2â¯mg), which showed good powder properties and improved dissolution of TCG. The solidified TCG-SM (Sol-TCG-SM), disintegrant (croscarmellose sodium), diluent (microcrystalline cellulose), binder (polyvinylpyrrolidone), and lubricant (magnesium stearate) were mixed to prepare granules. And, the granules with total weight of 900â¯mg were tableted using 16â¯mm oval-shape punch. The prepared Sol-TCG-SM tablet showed good tablet properties and maintained self-microemulsifying ability, such as microemulsion formation and enhanced dissolution of TCG. In vivo pharmacokinetic study, the relative bioavailability of Sol-TCG-SM exhibited 108.1% and 632.7% compared to TCG-SM and raw TCG powder, respectively. In conclusion, we successfully solidified SMEDDS with improved oral bioavailability of insoluble drugs such as TCG through a statistical design. This suggests a new approach that can be utilized in the production of solidified SMEDDS.
Subject(s)
Emulsions/chemistry , Solubility/drug effects , Ticagrelor/chemistry , Administration, Oral , Aluminum Compounds/chemistry , Animals , Biological Availability , Cellulose/chemistry , Chemistry, Pharmaceutical/methods , Drug Delivery Systems/methods , Excipients/chemistry , Magnesium Compounds/chemistry , Male , Powders/chemistry , Rats , Rats, Sprague-Dawley , Silicates/chemistry , Silicon Dioxide/chemistry , Tablets/chemistryABSTRACT
Ticagrelor (TGL), a P2Y12 receptor antagonist, is classified as biopharmaceutics classification system (BCS) class IV drug due to its poor solubility and permeability, resulting in low oral bioavailability. Nanostructured lipid carriers (NLC) are an efficient delivery system for the improvement of bioavailability of BCS class IV drugs. Hence, we prepared TGL-loaded NLC (TGL-NLC) to enhance the oral bioavailability and antiplatelet activity of TGL with a systemic design approach. The optimized TGL-NLC with Box-Behnken design showed a small particle size of 87.6 nm and high encapsulation efficiency of 92.1%. Scanning electron microscope (SEM), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD) were performed to investigate the characteristics of TGL-NLC. Furthermore, TGL-NLC exhibited biocompatible cytotoxicity against Caco-2 cells. Cellular uptake of TGL-NLC was 1.56-fold higher than that of raw TGL on Caco-2 cells. In pharmacokinetic study, the oral bioavailability of TGL-NLC was 254.99% higher than that of raw TGL. In addition, pharmacodynamic study demonstrated that the antiplatelet activity of TGL-NLC was superior to that of raw TGL, based on enhanced bioavailability of TGL-NLC. These results suggest that TGL-NLC can be applied for efficient oral absorption and antiplatelet activity of TGL.
ABSTRACT
An advanced organometallic catalyst based on N-heterocyclic carbene (NHC) coordinated FeCl3 has been synthesized and used to control the reaction rate in polyurethane (PUR) polymerization. The imidazolium (Im)-based NHC was functionalized on the surface of the supporting material of bead-type chloromethyl polystyrene (PS) resin. The PS-Im-FeCl3 catalyst was synthesized through the coordination reaction between Im and FeCl3. The successful formation, functional groups, structure, and geometry of the PS-Im-FeCl3 catalysts were confirmed by Fourier transform infrared and X-ray photoelectron spectroscopy techniques. A thin layer of Im was observed to be coated uniformly on the PS bead surface and FeCl3 nanoparticles were observed to cover the coating layer homogeneously, as determined by field-emission scanning electron microscopy, transmission electron microscopy, and energy dispersive X-ray spectroscopy measurements. The PUR polymerization reaction was investigated through viscosity measurements and non-isothermal activation energy calculations by differential scanning calorimetry analysis. Based on the viscosity measurements, delayed PUR polymerization was achieved using the PS-Im-FeCl3 catalyst system. The highest viscosity (6000 cP) was achieved without any catalyst, with triphenylene bismuth, and with the PS-Im-FeCl3 catalyst after 23, 5, and 25 h of reaction time, respectively. Furthermore, the calculated activation energies (E a) were 27.92 and 36.35 kJ mol-1 for the no-catalyst and the PS-Im-FeCl3 systems, respectively. Thus, the viscosity measurements and DSC analyses confirm that the PS-Im-FeCl3 catalyst considerably increases the PUR reaction time. The Im-FeCl3 catalyst supported by CMPS can control the reaction rate in PUR synthesis because of its high activity. Thus, the PS-Im-FeCl3 catalyst can be used as a curing retardant in the PUR industry.
ABSTRACT
Recently, double random phase encoding (DRPE) has been integrated with the photon counting (PC) imaging technique for the purpose of secure image authentication. In this scheme, the same key should be securely distributed and shared between the sender and receiver, but this is one of the most vexing problems of symmetric cryptosystems. In this study, we propose an efficient asymmetric image authentication scheme by combining the PC-DRPE and RSA algorithms, which solves key management and distribution problems. The retrieved image from the proposed authentication method contains photon-limited encrypted data obtained by means of PC-DRPE. Therefore, the original image can be protected while the retrieved image can be efficiently verified using a statistical nonlinear correlation approach. Experimental results demonstrate the feasibility of our proposed asymmetric image authentication method.
ABSTRACT
Photoinduced structural change (PSC) is a fundamental excited-state dynamic process in chemical and biological systems. However, precise control of PSC processes is very challenging, owing to the lack of guidelines for designing excited-state potential energy surfaces (PESs). A series of rationally designed butterfly-like phosphorescent binuclear platinum complexes that undergo controlled PSC by Pt-Pt distance shortening and exhibit tunable dual (greenish-blue and red) emission are herein reported. Based on the Bell-Evans-Polanyi principle, it is demonstrated how the energy barrier of the PSC, which can be described as a chemical-reaction-like process between the two energy minima on the first triplet excited-state PES, can be controlled by synthetic means. These results reveal a simple method to engineer the dual emission of molecular systems by manipulating PES to control PSC.
ABSTRACT
A butterfly-like phosphorescent platinum(II) binuclear complex can undergo a molecular structure change in which the Pt-Pt distance shortens upon photoexcitation, which leads to the formation of two distinct excited states and dual emission in the steady state, that is, greenish-blue emission from the high-energy excited state at the long Pt-Pt distance and red emission from the low-energy excited state at the short Pt-Pt distance. This photoinduced molecular structure change has a strong dependence on the molecule's surrounding environment, allowing its application as self-referenced luminescent sensor for solid-liquid phase change, viscosity, and temperature, with greenish-blue emission in solid matrix and rising red emission in molten liquid phase. With proper control of the surrounding media to manipulate the structural change and photophysical properties, a broad white emission can be achieved from this molecular butterfly.
ABSTRACT
SFA-PQT exhibits self-assembly via a fluorophobic effect in a non-fluorous solvent, which leads to an enhanced electrical performance. Ambipolar transistors and inverters with p- and n- type bilayers are enabled by the unique thermally reversible soluble-insoluble properties of SFA-PQT. More importantly, the hydrophobicity of SFA-PQT facilitates orthogonal hydrophobic patterning and a patterned inverter exhibits low voltage dissipation, a narrow transition zone, a high gain value, and negligible hysteresis.
ABSTRACT
This paper reports a novel and efficient strategy for fabricating sub-100 nm metal ring arrays using a simple printing process. Vertically aligned carbon nanotubes that are supported by hexagonally ordered channels of alumina matrices are used as a stamp to print nanoscale ring patterns, which is a very unique stamping platform that has never been reported. Using this strategy, uniform nanoring patterns of various metals can be directly printed onto a wide range of substrate surfaces under ambient conditions. Significantly, the size and interval of the printed nanorings can be systematically tuned by controlling the ring-shaped tip dimensions of the pristine stamps. An advanced example of these printable nanoscale metal ring arrays is explicitly embodied in this work by investigation of the plasmon resonances of metal nanorings with different sizes and intervals.
ABSTRACT
A new approach to improve the power conversion efficiency of polymer bulk-heterojunction solar cells is demonstrated by generating a silica-like passivation layer embedded along the three-dimensionally intertwined interfaces between the nanoscopic domains of P3HT and PCBM by addition of an aymmetric block copolymer containing a short organo-silica precursor.